Instead of feeling down, Maya and Maceo focus on what's still possible, pushing the boundaries of preconceived notions about ...

Its therapy aims to restore a key protein, UNC13A,which is often low or absent in ALS patients and has been linked to the progression of the disease. Green previously cofounded Maze Therapeutics ...

A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat amyotrophic lateral sclerosis with a new strategy. Trace Neuroscience ...

The latest version of Taipei MRT Route map can be found on the official website of Taipei MRT.

This November, I AM ALS, a nonprofit dedicated to helping people — both patients and family members — affected by amyotrophic lateral sclerosis (ALS), is launching a campaign focused on supporting ...

Molecular Mimicry: The Role of MAP2694, MAPFprB & Mycobacterial Heat Shock Proteins It is still premature to conclude whether cross-recognition between MAP proteins/homologous human proteins ...

Recent studies have employed mathematical models drawn from epidemiology (the study of how diseases occur in the population and why). These models were originally developed to study the spread of ...

Sander van der Linden has engaged in consultancy for and received research funding from Google, the EU Commission, United Nations (UN), World Health Organization (WHO), Alfred Landecker Foundation ...

Biotech company Auttx has received a $125,000 grant to advance the development of new molecules that aim to restore normal RNA processing in people with amyotrophic lateral sclerosis (ALS), ...

“He just looked at his phone and looked up the diagnosis when the doctor said you have ALS. He didn’t know what ALS was. Still doesn’t really know what ALS is. He said, I looked at my phone ...

Recent findings propose that Mycobacterium avium subsp. paratuberculosis (MAP) infection could be a risk factor favoring MS progression in the Sardinian population. MAP DNA was detected in the ...